Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
GENELINK INC (GNLK)
|
Add to portfolio |
|
|
|
| Price: |
$0.06
| | Metrics |
| OS: |
265.0
|
M
| |
|
|
| Market cap: |
$15.9
|
M
| |
|
|
|
Net debt:
|
$1.06
|
M
| |
|
|
|
EV:
|
$17
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($1.3)
|
M
| |
|
|
|
EBIT
|
($1.3)
|
M
| |
|
|
| EPS |
($0.01)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 |
| Revenues | 2.1 | 4.7 | 7.8 | 8.6 | 6.4 | 0.1 |
| Revenue growth | -54.4% | -40.2% | -8.4% | 34.2% | 6424.6% | |
| Cost of goods sold | 1.7 | 1.7 | 2.9 | 3.7 | 1.8 | 0.1 |
| Gross profit | 0.5 | 2.9 | 5.0 | 4.9 | 4.6 | 0.0 |
| Gross margin | 21.8% | 63.0% | 63.5% | 57.3% | 71.6% | 27.6% |
| Selling, general and administrative | 3.4 | 6.2 | 7.2 | 7.3 | 6.7 | 1.3 |
| Research and development | 0.3 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
| EBIT | -2.7 | -3.6 | -2.4 | -2.5 | -2.2 | -1.3 |
| EBIT margin | -124.4% | -76.1% | -30.6% | -28.8% | -35.0% | -1294.7% |
| Pre-tax income | -3.1 | -3.8 | -2.6 | -2.7 | -2.6 | -1.6 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -3.1 | -3.8 | -2.6 | -2.7 | -2.6 | -1.6 |
| Net margin | -142.9% | -81.8% | -33.6% | -31.7% | -40.8% | -1596.6% |
| |
| Diluted EPS | ($0.01) | ($0.02) | ($0.02) | ($0.03) | ($0.03) | ($0.03) |
| Shares outstanding (diluted) | 214.4 | 180.6 | 134.8 | 90.6 | 86.8 | 52.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|